The Fatty Liver Foundation is very concerned about poor antibody response for many in our community who are immune-compromised. Many chronic conditions can affect the immune system beyond the obvious transplant patients. The CDC is "studying" the matter. I believe we need to speak to this issue as a patient community. Please take this short survey about the vaccine. We need the people we speak with to understand that there are a lot of us who are concerned about this issue. This is an anonymous survey.
The Foundation is working on the prob... - Living with Fatty...
The Foundation is working on the problem of COVID vaccine and immune compromised patients like us. Please help by taking the survey.
Written by
nash2
Partner
To view profiles and participate in discussions please or .
4 Replies
•
Done.
Also done.
Done
Done
Not what you're looking for?
You may also like...
I need your help, will you help us by taking our survey? Take a look at the link below for more information.
Announcing The State of NAFLD/NASH Care in America Survey
This 2022 State of Care Survey is the...
Will you take 90 Seconds to Help Improve healthcare for people with NAFLD/NASH? A note from Wayne
First of all, let me thank you in advance for taking this short survey. This may help the patient...
The State of NAFLD/NASH Care in America 2023 is Live - We Need Your Voice
Hi community members,
Last year, many of you generously took the time to share your patient...
Will You Take Our Survey Seeking NAFLD/NASH Patient Voices?
Hi everyone,
My name is Tiffany and I'm joining FLF as a Program Coordinator - I'm so excited to...
Are forums like this of any value to patients really?
A recent survey of forum participants had some interesting results
•66% of users have not met...
Related Posts
- The sky is falling -- we are doomed -- well maybe not
- How to get a 3rd vaccine booster
- CBD OIL a triumph of hope over reason? What matters?
- Health in the land of unintended consequences. Do you know about the risks of dietary supplements?
- I need help from a few NAFLD/NASH patients who are willing to tell their stories and perhaps participate in a panel discussion.
